We provide you with 20 years of free, institutional-grade data for COLL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of COLL. Explore the full financial landscape of COLL stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-07 | 1267565 | COLL | 10-Q | Url |
| 2025-05-08 | 1267565 | COLL | 10-Q | Url |
| 2025-02-27 | 1267565 | COLL | 10-K | Url |
| 2024-11-07 | 1267565 | COLL | 10-Q | Url |
| 2024-08-08 | 1267565 | COLL | 10-Q | Url |
| 2024-05-09 | 1267565 | COLL | 10-Q | Url |
| 2024-02-22 | 1267565 | COLL | 10-K | Url |
| 2023-11-07 | 1267565 | COLL | 10-Q | Url |
| 2023-08-03 | 1267565 | COLL | 10-Q | Url |
| 2023-05-04 | 1267565 | COLL | 10-Q | Url |
| 2023-02-23 | 1267565 | COLL | 10-K | Url |
| 2022-11-03 | 1267565 | COLL | 10-Q | Url |
| 2022-08-04 | 1267565 | COLL | 10-Q | Url |
| 2022-05-10 | 1267565 | COLL | 10-Q | Url |
| 2022-02-24 | 1267565 | COLL | 10-K | Url |
| 2021-11-04 | 1267565 | COLL | 10-Q | Url |
| 2021-08-05 | 1267565 | COLL | 10-Q | Url |
| 2021-05-06 | 1267565 | COLL | 10-Q | Url |
| 2021-02-25 | 1267565 | COLL | 10-K | Url |
| 2020-11-05 | 1267565 | COLL | 10-Q | Url |
| 2020-08-05 | 1267565 | COLL | 10-Q | Url |
| 2020-05-07 | 1267565 | COLL | 10-Q | Url |
| 2020-02-27 | 1267565 | COLL | 10-K | Url |
| 2019-11-06 | 1267565 | COLL | 10-Q | Url |
| 2019-08-07 | 1267565 | COLL | 10-Q | Url |
| 2019-05-08 | 1267565 | COLL | 10-Q | Url |
| 2019-02-27 | 1267565 | COLL | 10-K | Url |
| 2018-11-08 | 1267565 | COLL | 10-Q | Url |
| 2018-08-08 | 1267565 | COLL | 10-Q | Url |
| 2018-05-09 | 1267565 | COLL | 10-Q | Url |
| 2018-03-07 | 1267565 | COLL | 10-K | Url |
| 2017-11-08 | 1267565 | COLL | 10-Q | Url |
| 2017-08-09 | 1267565 | COLL | 10-Q | Url |
| 2017-05-10 | 1267565 | COLL | 10-Q | Url |
| 2017-03-10 | 1267565 | COLL | 10-K | Url |
| 2016-11-10 | 1267565 | COLL | 10-Q | Url |
| 2016-08-11 | 1267565 | COLL | 10-Q | Url |
| 2016-05-11 | 1267565 | COLL | 10-Q | Url |
| 2016-03-18 | 1267565 | COLL | 10-K | Url |
| 2015-12-18 | 1267565 | COLL | S-1 | Url |
| 2015-11-12 | 1267565 | COLL | 10-Q | Url |
| 2015-08-12 | 1267565 | COLL | 10-Q | Url |
| 2015-06-22 | 1267565 | COLL | 10-Q | Url |
| 2015-04-02 | 1267565 | COLL | S-1 | Url |
Collegium Pharmaceutical, Inc(NASDAQ:COLL) 
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immedia...
Website: http://www.collegiumpharma.com
Founded: 2002
Full Time Employees: 255
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report about COLL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.